The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

Pacchiarotti, Isabella; Bond, David; Baldessarini, Ross; Nolen, Willem; Grunze, Heinz; Licht, Rasmus; Post, Robert; Berk, Michael; Goodwin, Guy; Sachs, Gary; Tondo, Leonardo; Findling, Robert; Youngstrom, Eric; Tohen, Mauricio; Undurraga, Juan; Gonzalez-Pinto, Ana; Goldberg, Joseph; Yildiz, AYŞEGÜL; Altshuler, Lori; Calabrese, Joseph; Mitchell, Philip; Thase, Michael; Koukopoulos, Athanasios; Colom, Francesc; Frye, Mark; Malhi, Gin; Fountoulakis, Konstantinos; Vazquez, Gustavo; Perlis, Roy; Ketter, Terence; Cassidy, Frederick; Akiskal, Hagop; Azorin, Jean-Michel; Valenti, Marc; Mazzei, Diego; Lafer, Beny; Kato, Tadafumi; Mazzarini, Lorenzo; Martinez-Aran, Anabel; Parker, Gordon; Souery, Daniel; Ozerdem, Aysegul; McElroy, Susan; Girardi, Paolo; Bauer, Michael; Yatham, Lakshmi; Zarate, Carlos; Nierenberg, Andrew; Birmaher, Boris; Kanba, Shigenobu; El-Mallakh, Rif; Serretti, Alessandro; Rihmer, Zoltan; Young, Allan; Kotzalidis, Georgios; MacQueen, Glenda; Bowden, Charles; Ghaemi, S.; Lopez-Jaramillo, Carlos; Rybakowski, Janusz; Ha, Kyooseob; Perugi, Giulio; Kasper, Siegfried; Amsterdam, Jay; Hirschfeld, Robert; Kapczinski, Flavio; Vieta, Eduard

doi:10.1176/appi.ajp.2013.13020185

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

Pacchiarotti I., Bond D. J., Baldessarini R. J., Nolen W. A., Grunze H., Licht R. W., ...More

AMERICAN JOURNAL OF PSYCHIATRY, vol.170, no.11, pp.1249-1262, 2013 (SCI-Expanded, SSCI, Scopus)

Publication Type: Article / Review
Volume: 170 Issue: 11
Publication Date: 2013
Doi Number: 10.1176/appi.ajp.2013.13020185
Journal Name: AMERICAN JOURNAL OF PSYCHIATRY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
Page Numbers: pp.1249-1262
Open Archive Collection: AVESIS Open Access Collection
Dokuz Eylül University Affiliated: No

Abstract

Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions. The International Society for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations on the use of antidepressants in bipolar disorders.